Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT - AMI Investigators - Ohman, EM; Kleiman, NS; Gacioch, G (Circulation, 1997)
et al.